
LeadArtis
Looking for Partnership Looking for Extra EU Funds
LeadArtis is an early stage biotechnology company based in Madrid (Spain) that develops targeted drugs based on its proprietary Trimerbody® protein engineering platform.
Trimerbody® is an alternative antibody format that employs specific collagen trimerization domains and optimized peptide connectors to provide advantages over conventional antibodies including simultaneous multiple targeting (up to six per molecule), reduced size, higher avidity for targets, and a variety of effector possibilities such as immune system modulation, receptor modulation, soluble factor neutralization, payload delivery etc. Our key therapeutic areas for pipeline development are oncology and inflammatory/autoimmunity.
Additionally, we offer our Trimerbody® platform to partners interested in developing targeted drugs benefiting from the Trimerbody® format which offers promising opportunities over competitors including pharmacokinetics adapted to the pathological context.
Keywords and matching areas:
Get Access to the 1st Network for European Cooperation
Log In
or
Create an account
to see this content
Entrepreneurship and SMEs
Biotechnology
Cross-border cooperation
Horizon Europe
Research
Fundraising
7 years ago
Please Log In to See This Section